Katrine Bosley Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Katrine Bosley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Katrine Bosley. Katrine Bosley is Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and President and CEO in Editas Medicine, Inc. ($EDIT).
Latest Insider Trading Transactions of Katrine Bosley
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | Bosley Katrine | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Bosley Katrine | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
Jan 10 2019 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 25.27 | 12,000 | 303,240 | 1,204,966 | 1.2 M to 1.2 M (-0.99 %) |
Dec 06 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 32.39 | 100 | 3,239 | 1,216,966 | 1.2 M to 1.2 M (-0.01 %) |
Dec 06 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 31.92 | 11,900 | 379,848 | 1,217,066 | 1.2 M to 1.2 M (-0.97 %) |
Nov 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 27.21 | 8,600 | 234,006 | 1,228,966 | 1.2 M to 1.2 M (-0.69 %) |
Nov 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 26.03 | 3,400 | 88,502 | 1,237,566 | 1.2 M to 1.2 M (-0.27 %) |
Oct 03 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 31.44 | 5,766 | 181,283 | 1,240,966 | 1.2 M to 1.2 M (-0.46 %) |
Oct 03 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 30.64 | 6,234 | 191,010 | 1,246,732 | 1.3 M to 1.2 M (-0.50 %) |
Sep 06 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 33.07 | 1,213 | 40,114 | 1,252,966 | 1.3 M to 1.3 M (-0.10 %) |
Sep 06 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 32.27 | 10,787 | 348,096 | 1,254,179 | 1.3 M to 1.3 M (-0.85 %) |
Aug 22 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 30.43 | 5,433 | 165,326 | 1,264,966 | 1.3 M to 1.3 M (-0.43 %) |
Aug 22 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 29.95 | 6,567 | 196,682 | 1,270,399 | 1.3 M to 1.3 M (-0.51 %) |
Aug 03 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 30.12 | 2,100 | 63,252 | 1,276,966 | 1.3 M to 1.3 M (-0.16 %) |
Aug 03 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 29.36 | 6,233 | 183,001 | 1,279,066 | 1.3 M to 1.3 M (-0.48 %) |
Jul 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 36.46 | 5,333 | 194,441 | 1,285,299 | 1.3 M to 1.3 M (-0.41 %) |
Jul 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 36.00 | 3,000 | 108,000 | 1,290,632 | 1.3 M to 1.3 M (-0.23 %) |
Jun 25 2018 | GNCA | GENOCEA BIOSCIENCE ... | Bosley Katrine | Director | Option Exercise | A | 0.99 | 45,000 | 44,550 | 45,000 | |
Jun 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 39.96 | 300 | 11,988 | 1,293,632 | 1.3 M to 1.3 M (-0.02 %) |
Jun 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 39.15 | 800 | 31,320 | 1,293,932 | 1.3 M to 1.3 M (-0.06 %) |
Jun 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 37.81 | 1,019 | 38,528 | 1,294,732 | 1.3 M to 1.3 M (-0.08 %) |
Jun 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 37.18 | 6,214 | 231,037 | 1,295,751 | 1.3 M to 1.3 M (-0.48 %) |
May 03 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 31.95 | 8,333 | 266,239 | 1,301,965 | 1.3 M to 1.3 M (-0.64 %) |
Apr 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 32.61 | 3,500 | 114,135 | 1,310,298 | 1.3 M to 1.3 M (-0.27 %) |
Apr 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 31.83 | 4,833 | 153,834 | 1,313,798 | 1.3 M to 1.3 M (-0.37 %) |
Mar 13 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 45.00 | 9,134 | 411,030 | 1,318,631 | 1.3 M to 1.3 M (-0.69 %) |
Mar 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 36.41 | 1,800 | 65,538 | 1,327,765 | 1.3 M to 1.3 M (-0.14 %) |
Mar 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 35.87 | 4,800 | 172,176 | 1,329,565 | 1.3 M to 1.3 M (-0.36 %) |
Mar 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 34.61 | 1,733 | 59,979 | 1,334,365 | 1.3 M to 1.3 M (-0.13 %) |
Feb 09 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Option Exercise | A | 36.67 | 275,000 | 10,084,250 | 275,000 | |
Feb 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 37.60 | 700 | 26,322 | 1,336,098 | 1.3 M to 1.3 M (-0.05 %) |
Feb 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 36.71 | 2,100 | 77,097 | 1,336,798 | 1.3 M to 1.3 M (-0.16 %) |
Feb 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 35.79 | 5,533 | 198,032 | 1,338,898 | 1.3 M to 1.3 M (-0.41 %) |
Jan 31 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 40.05 | 10,000 | 400,520 | 1,344,431 | 1.4 M to 1.3 M (-0.74 %) |
Jan 31 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 37.53 | 10,000 | 375,340 | 1,354,431 | 1.4 M to 1.4 M (-0.73 %) |
Jan 25 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 35.28 | 3,338 | 117,765 | 1,364,431 | 1.4 M to 1.4 M (-0.24 %) |
Jan 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 35.04 | 6,662 | 233,416 | 1,367,769 | 1.4 M to 1.4 M (-0.48 %) |
Jan 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 34.23 | 3,937 | 134,744 | 1,374,431 | 1.4 M to 1.4 M (-0.29 %) |
Jan 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 33.63 | 2,193 | 73,759 | 1,378,368 | 1.4 M to 1.4 M (-0.16 %) |
Jan 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 32.01 | 1,703 | 54,510 | 1,380,561 | 1.4 M to 1.4 M (-0.12 %) |
Jan 04 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 31.25 | 500 | 15,624 | 1,382,264 | 1.4 M to 1.4 M (-0.04 %) |
Dec 05 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 29.88 | 5,133 | 153,348 | 1,382,764 | 1.4 M to 1.4 M (-0.37 %) |
Dec 05 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 29.12 | 3,200 | 93,174 | 1,387,897 | 1.4 M to 1.4 M (-0.23 %) |
Nov 03 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 25.05 | 300 | 7,514 | 1,391,097 | 1.4 M to 1.4 M (-0.02 %) |
Nov 03 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 24.25 | 1,925 | 46,679 | 1,391,397 | 1.4 M to 1.4 M (-0.14 %) |
Nov 03 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 23.37 | 6,108 | 142,773 | 1,393,322 | 1.4 M to 1.4 M (-0.44 %) |
Oct 04 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 25.33 | 200 | 5,066 | 1,399,430 | 1.4 M to 1.4 M (-0.01 %) |
Oct 04 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 24.77 | 8,133 | 201,459 | 1,399,630 | 1.4 M to 1.4 M (-0.58 %) |
Sep 06 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 20.20 | 6,666 | 134,681 | 1,407,763 | 1.4 M to 1.4 M (-0.47 %) |
Sep 06 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 21.20 | 200 | 4,239 | 1,414,429 | 1.4 M to 1.4 M (-0.01 %) |
Sep 06 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 20.40 | 9,800 | 199,911 | 1,414,629 | 1.4 M to 1.4 M (-0.69 %) |
Jun 15 2017 | GNCA | GENOCEA BIOSCIENCE ... | Bosley Katrine | Director | Option Exercise | A | 5.34 | 15,000 | 80,100 | 15,000 | |
Jun 15 2017 | GNCA | GENOCEA BIOSCIENCE ... | Bosley Katrine | Director | Option Exercise | A | 5.34 | 15,000 | 80,100 | 15,000 | |
Mar 03 2017 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Option Exercise | A | 24.60 | 312,000 | 7,675,200 | 312,000 | |
Jun 07 2016 | GNCA | GENOCEA BIOSCIENCE ... | Bosley Katrine | Director | Option Exercise | A | 4.64 | 15,000 | 69,600 | 15,000 | |
Feb 09 2016 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Option Exercise | C | 0.00 | 11,111 | 0 | 0 | |
Feb 09 2016 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Option Exercise | C | 0.00 | 192,027 | 0 | 0 | |
Feb 09 2016 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Buy | C | 0.00 | 4,273 | 0 | 1,441,095 | 1.4 M to 1.4 M (+0.30 %) |
Feb 09 2016 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Buy | C | 0.00 | 73,856 | 0 | 1,436,822 | 1.4 M to 1.4 M (+5.42 %) |
Feb 04 2016 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Option Exercise | A | 16.00 | 38,461 | 615,376 | 38,461 | |
Mar 02 2015 | GNCA | GENOCEA BIOSCIENCE ... | Bosley Katrine | Director | Option Exercise | A | 9.08 | 5,042 | 45,781 | 5,042 |
Page: 1